Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

ClinicalTrials.gov ID: NCT05557409

Public ClinicalTrials.gov record NCT05557409. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ADVANCE-2: Addressing Dementia Via Agitation-Centered Evaluation 2: A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Alzheimer's Disease Agitation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial was a multi-center, double-blind, placebo-controlled, randomized study to evaluate the efficacy and safety of AXS-05 compared to placebo for the treatment of agitation associated with Alzheimer's disease.

Study identification

NCT ID
NCT05557409
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
408 participants

Conditions and interventions

Eligibility (public fields only)

Age range
65 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 6, 2022 (Actual)
Primary completion
Nov 21, 2024 (Actual)
Completion
Dec 21, 2024 (Actual)
Last update posted
Aug 13, 2026

2022 – 2024

United States locations

U.S. sites
53
U.S. states
16
U.S. cities
46
Facility City State ZIP Site status
Clinical Research Site Peoria Arizona 85381 —
Clinical Research Site Tempe Arizona 85282 —
Clinical Research Site Tucson Arizona 85710 —
Clinical Research Site Canoga Park California 91303 —
Clinical Research Site Long Beach California 90807 —
Clinical Research Site Los Alamitos California 90720 —
Clinical Research Site Walnut Creek California 94596 —
Clinical Research Site West Covina California 91790 —
Clinical Research Site Bonita Springs Florida 34134 —
Clinical Research Site Brandon Florida 33511 —
Clinical Research Site Green Acres Florida 33467 —
Clinical Research Site Hialeah Florida 33012 —
Clinical Research Site Hollywood Florida 33024 —
Clinical Research Site Kissimmee Florida 34741 —
Clinical Research Site Miami Florida 33126 —
Clinical Research Site Miami Florida 33135 —
Clinical Research Site Miami Florida 33145 —
Clinical Research Site Miami Florida 33155 —
Clinical Research Site Miami Florida 33165 —
Clinical Research Site Miami Florida 33173 —
Clinical Research Site Miami Florida 33175 —
Clinical Research Site Miami Gardens Florida 33014 —
Clinical Research Site Miami Lakes Florida 33014 —
Clinical Research Site Orlando Florida 32807 —
Clinical Research Site Pembroke Pines Florida 33025 —
Clinical Research Site Tampa Florida 33614 —
Clinical Research Site Tampa Florida 33634 —
Clinical Research Site Augusta Georgia 30912 —
Clinical Research Site College Park Georgia 30349 —
Clinical Research Site Columbus Georgia 31909 —
Clinical Research Site Wichita Kansas 67214 —
Clinical Research Site Marrero Louisiana 70072 —
Clinical Research Site Braintree Massachusetts 02184 —
Clinical Research Site Flint Michigan 48532 —
Clinical Research Site Rochester Hills Michigan 48307 —
Clinical Research Site Troy Michigan 48085 —
Clinical Research Site Chesterfield Missouri 63005 —
Clinical Research Site Berlin New Jersey 08009 —
Clinical Research Site Toms River New Jersey 08755 —
Clinical Research Site Brooklyn New York 11229 —
Clinical Research Site New Windsor New York 12553 —
Clinical Research Site Staten Island New York 10314 —
Clinical Research Site Woodmere New York 11598 —
Clinical Research Site Charlotte North Carolina 28211 —
Clinical Research Site Hickory North Carolina 28601 —
Clinical Research Site Middleburg Heights Ohio 44130 —
Clinical Research Site Austin Texas 78737 —
Clinical Research Site Cypress Texas 77429 —
Clinical Research Site Mesquite Texas 75149 —
Clinical Research Site San Antonio Texas 78229 —
Clinical Research Site Sugarland Texas 77478 —
Clinical Research Site Rutland Vermont 05701 —
Clinical Research Site Arlington Virginia 22205 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05557409, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 13, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05557409 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →